<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04963036</url>
  </required_header>
  <id_info>
    <org_study_id>B0762021210506</org_study_id>
    <nct_id>NCT04963036</nct_id>
  </id_info>
  <brief_title>Impact of Nociception Level (NOL)-Guided Remifentanil Infusion on Intraoperative Arterial Pressure and Vasopressor Necessity</brief_title>
  <official_title>Impact of Nociception Level (NOL)-Guided Remifentanil Infusion and Entropy-guided Propofol Infusion on Intraoperative Arterial Pressure and Vasopressor Necessity A Prospective, Randomized, Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Saint Pierre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Saint Pierre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine if Nociception Level (NOL)-guided Remifentanil&#xD;
      analgesia, combined with Entropy-guided Propofol anesthesia, has a significant beneficial&#xD;
      effect on the incidence of intraoperative hypotension episodes and/or on vasopressor&#xD;
      requirements, during long-lasting major surgeries for high risk patients. The investigator&#xD;
      will also investigate the effects of guided anesthesia on postoperative Myocardial Injury in&#xD;
      Non-cardiac Surgery (MINS) and Postoperative cognitive dysfunction (POCD), amongst other&#xD;
      frequent postoperative complications, in this population.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of intraoperative hypotension</measure>
    <time_frame>during surgery</time_frame>
    <description>Occurrence of intraoperative hypotension is defined by at least 1 minute under the hypotension thresholds.&#xD;
Moderate and Severe Hypotension are respectively defined as a Mean Blood Pressure &lt;65 mmHg or &lt;55 mmHg and &lt;75 or &lt;65 mmHg for patient with history of chronic hypertension</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Vasopressor Dose</measure>
    <time_frame>during surgery</time_frame>
    <description>Total Vasopressor Dose used throughout the intervention to maintain Arterial Pressure within a pre-defined individualized ranges (≥ 65 mmHg or ≥75 mmHg for patient with history of chronic hypertension, and ≤ 100 mmHg)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of interventions to cure intraoperative hypotension</measure>
    <time_frame>during surgery</time_frame>
    <description>Number of vasopressor boli or vasopressor infusion dose adjustments</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Time under hypotension thresholds</measure>
    <time_frame>during surgery</time_frame>
    <description>Hypotension Thresholds ( &lt;65 mmHg or &lt; 75mmHg for patient with history of chronic hypertension)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Myocardial Injury in Non-Cardiac Surgery (MINS) marker (Troponin T)</measure>
    <time_frame>up to 48 hours after surgery</time_frame>
    <description>Troponin T level measured before surgery, at end of surgery, 4 hours, 8 hours, 24 hours, 36 hours and 48 hours after surgery. The threshold is a postoperative concentration ≥ 20 ng/L with an increase from baseline of at least 5 ng/L, or a postoperative concentration ≥ 65 ng/L.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Acute Kidney Injury (AKI) marker (creatinin/Glomerular Filtration Rate)</measure>
    <time_frame>up to 48 hours after surgery</time_frame>
    <description>Creatinin level measured before surgery, at end of surgery, 24 hours and 48 hours after surgery. The thresholds are defined by the Kidney Disease: Improving Global Outcomes (KDIGO) classification without the oliguria criteria.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Cognitive Decline (POCD)</measure>
    <time_frame>up to 6 months after surgery</time_frame>
    <description>POCD will be evaluated by cognitive dysfunction battery tests (written Montreal Cognitive Assessment (MOCA) Test) at days 5,10, 15, hospital discharge, 3 and 6 postoperative months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PostOperative Delirium (PO Delirium)</measure>
    <time_frame>up to 6 months after surgery</time_frame>
    <description>PO Delirium will be evaluated by the Confusion Assessment Method (CAM) at days 5, 10, 15, hospital discharge, 3 and 6 postoperative months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dosage of Stress Hormones</measure>
    <time_frame>up to 4 hours after surgery</time_frame>
    <description>Adrenocorticotropic Hormone (ACTH) and Cortisol will be measured in blood samples at the end of surgery, at the arrival in the ICU and at 4 hours after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dosage of Neuro-Inflammatory Markers</measure>
    <time_frame>up to 48 hours after surgery</time_frame>
    <description>Interleukine-6 and Interleukine-8 will be measured in blood and saliva samples before surgery and during the postoperative period (4 hours, 24 hours and 48 hours after surgery).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Olfactory Function assessment as an indicator of Neuro-Inflammation</measure>
    <time_frame>up to 48 hours after surgery</time_frame>
    <description>A rapid quantitative olfactory function test, the University of Pennsylvania Smell Identification -Test (UPSIT-Test) will be performed before surgery and during the postoperative period (4 hours, 24 hours and 48 hours after surgery).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Intensive Unit Care (IUC) stay</measure>
    <time_frame>up to 10 Days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>up to 15 Days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Event (blood loss, infection)</measure>
    <time_frame>up to 15 Days after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Head and Neck Surgery</condition>
  <condition>Maxillofacial Surgery</condition>
  <arm_group>
    <arm_group_label>Entropy and NOL-Guided Goal Directed Anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care Group (Entropy and blinded NOL)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Entropy and NOL-Guided Goal Directed Anesthesia</intervention_name>
    <description>Entropy-guided Anesthesia (Propofol infusion in order to maintain Entropy between 45 and 55) and NOL-guided Analgesia (Remifentanil infusion in order to maintain NOL-Index between 10 and 25).</description>
    <arm_group_label>Entropy and NOL-Guided Goal Directed Anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard of Care Group (Entropy and blinded NOL)</intervention_name>
    <description>Entropy-guided Anesthesia (Propofol infusion in order to obtain Entropy between 45 and 55) and Remifentanil infusion at the discretion of the anesthetist in charge, based on current practice: patient vitals (Heart Rate, Blood Pressure, Respiratory Rate…), movements, spontaneous breathing, experience....&#xD;
In this group, nociception monitor screen will be concealed and the NOL index will not be available for guidance of remifentanil dosing).</description>
    <arm_group_label>Standard of Care Group (Entropy and blinded NOL)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥18&#xD;
&#xD;
          -  Elective high-risk head and neck or maxillo-facial surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient refusal&#xD;
&#xD;
          -  Reduced ejection fraction below 40% and heart failure&#xD;
&#xD;
          -  History of atrial Fibrillation, pulmonary embolism, recent cardioversion, recent&#xD;
             cardiac ischemic episode, chronic hypotension, chronic kidney insufficiency (serum&#xD;
             creatinine &gt; 1.5)&#xD;
&#xD;
          -  Septic state&#xD;
&#xD;
          -  Baseline heart-rate &lt; 50 or &gt; 90 bpm&#xD;
&#xD;
          -  History of psychiatric disease or medication&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Panayota Kapessidou, MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital Saint-Pierre (CHU Saint-Pierre), Université Libre de Bruxelles (ULB)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mehdi M'rini, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Saint-Pierre (CHU Saint-Pierre), Université Libre de Bruxelles (ULB)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Panayota Kapessidou, MD,PhD</last_name>
    <phone>+32.2.535</phone>
    <phone_ext>3750</phone_ext>
    <email>pkapessi@ulb.ac.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mehdi M'rini, MD</last_name>
    <phone>+32.2.535</phone>
    <phone_ext>3783</phone_ext>
    <email>m.mrini@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Saint-Pierre</name>
      <address>
        <city>Bruxelles</city>
        <zip>1000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <contact>
      <last_name>Panayota Kapessidou, MD,PhD</last_name>
      <phone>+32.2.535</phone>
      <phone_ext>3750</phone_ext>
      <email>pkapessi@ulb.ac.be</email>
    </contact>
    <contact_backup>
      <last_name>Medhi M'rini, MD</last_name>
      <phone>+32.2.535</phone>
      <phone_ext>3783</phone_ext>
      <email>m.mrini@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Saugel B, Sessler DI. Perioperative Blood Pressure Management. Anesthesiology. 2021 Feb 1;134(2):250-261. doi: 10.1097/ALN.0000000000003610. Review.</citation>
    <PMID>33206118</PMID>
  </reference>
  <reference>
    <citation>Sessler DI, Khanna AK. Perioperative myocardial injury and the contribution of hypotension. Intensive Care Med. 2018 Jun;44(6):811-822. doi: 10.1007/s00134-018-5224-7. Epub 2018 Jun 4. Review.</citation>
    <PMID>29868971</PMID>
  </reference>
  <reference>
    <citation>Ruetzler K, Khanna AK, Sessler DI. Myocardial Injury After Noncardiac Surgery: Preoperative, Intraoperative, and Postoperative Aspects, Implications, and Directions. Anesth Analg. 2020 Jul;131(1):173-186. doi: 10.1213/ANE.0000000000004567. Review.</citation>
    <PMID>31880630</PMID>
  </reference>
  <reference>
    <citation>Krzych ŁJ, Pluta MP, Putowski Z, Czok M. Investigating Association between Intraoperative Hypotension and Postoperative Neurocognitive Disorders in Non-Cardiac Surgery: A Comprehensive Review. J Clin Med. 2020 Sep 30;9(10). pii: E3183. doi: 10.3390/jcm9103183. Review.</citation>
    <PMID>33008109</PMID>
  </reference>
  <reference>
    <citation>Feng X, Hu J, Hua F, Zhang J, Zhang L, Xu G. The correlation of intraoperative hypotension and postoperative cognitive impairment: a meta-analysis of randomized controlled trials. BMC Anesthesiol. 2020 Aug 5;20(1):193. doi: 10.1186/s12871-020-01097-5.</citation>
    <PMID>32758153</PMID>
  </reference>
  <reference>
    <citation>Greaves D, Psaltis PJ, Davis DHJ, Ross TJ, Ghezzi ES, Lampit A, Smith AE, Keage HAD. Risk Factors for Delirium and Cognitive Decline Following Coronary Artery Bypass Grafting Surgery: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2020 Nov 17;9(22):e017275. doi: 10.1161/JAHA.120.017275. Epub 2020 Nov 7.</citation>
    <PMID>33164631</PMID>
  </reference>
  <reference>
    <citation>Belrose JC, Noppens RR. Anesthesiology and cognitive impairment: a narrative review of current clinical literature. BMC Anesthesiol. 2019 Dec 27;19(1):241. doi: 10.1186/s12871-019-0903-7. Review.</citation>
    <PMID>31881996</PMID>
  </reference>
  <reference>
    <citation>Walsh M, Devereaux PJ, Garg AX, Kurz A, Turan A, Rodseth RN, Cywinski J, Thabane L, Sessler DI. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013 Sep;119(3):507-15. doi: 10.1097/ALN.0b013e3182a10e26.</citation>
    <PMID>23835589</PMID>
  </reference>
  <reference>
    <citation>Evered LA, Silbert BS. Postoperative Cognitive Dysfunction and Noncardiac Surgery. Anesth Analg. 2018 Aug;127(2):496-505. doi: 10.1213/ANE.0000000000003514. Review.</citation>
    <PMID>29889707</PMID>
  </reference>
  <reference>
    <citation>Ledowski T. Monitoring nociception-getting 'there yet' might be easier with a road map. Br J Anaesth. 2017 Oct 1;119(4):716-717. doi: 10.1093/bja/aex277.</citation>
    <PMID>29121306</PMID>
  </reference>
  <reference>
    <citation>Ledowski T. Objective monitoring of nociception: a review of current commercial solutions. Br J Anaesth. 2019 Aug;123(2):e312-e321. doi: 10.1016/j.bja.2019.03.024. Epub 2019 Apr 30. Review.</citation>
    <PMID>31047645</PMID>
  </reference>
  <reference>
    <citation>De Jonckheere J, Bonhomme V, Jeanne M, Boselli E, Gruenewald M, Logier R, Richebé P. Physiological Signal Processing for Individualized Anti-nociception Management During General Anesthesia: a Review. Yearb Med Inform. 2015 Aug 13;10(1):95-101. doi: 10.15265/IY-2015-004. Review.</citation>
    <PMID>26293855</PMID>
  </reference>
  <reference>
    <citation>Martini CH, Boon M, Broens SJ, Hekkelman EF, Oudhoff LA, Buddeke AW, Dahan A. Ability of the nociception level, a multiparameter composite of autonomic signals, to detect noxious stimuli during propofol-remifentanil anesthesia. Anesthesiology. 2015 Sep;123(3):524-34. doi: 10.1097/ALN.0000000000000757.</citation>
    <PMID>26154185</PMID>
  </reference>
  <reference>
    <citation>Meijer F, Honing M, Roor T, Toet S, Calis P, Olofsen E, Martini C, van Velzen M, Aarts L, Niesters M, Boon M, Dahan A. Reduced postoperative pain using Nociception Level-guided fentanyl dosing during sevoflurane anaesthesia: a randomised controlled trial. Br J Anaesth. 2020 Dec;125(6):1070-1078. doi: 10.1016/j.bja.2020.07.057. Epub 2020 Sep 17.</citation>
    <PMID>32950246</PMID>
  </reference>
  <reference>
    <citation>Futier E, Lefrant JY, Guinot PG, Godet T, Lorne E, Cuvillon P, Bertran S, Leone M, Pastene B, Piriou V, Molliex S, Albanese J, Julia JM, Tavernier B, Imhoff E, Bazin JE, Constantin JM, Pereira B, Jaber S; INPRESS Study Group. Effect of Individualized vs Standard Blood Pressure Management Strategies on Postoperative Organ Dysfunction Among High-Risk Patients Undergoing Major Surgery: A Randomized Clinical Trial. JAMA. 2017 Oct 10;318(14):1346-1357. doi: 10.1001/jama.2017.14172.</citation>
    <PMID>28973220</PMID>
  </reference>
  <reference>
    <citation>Meijer FS, Martini CH, Broens S, Boon M, Niesters M, Aarts L, Olofsen E, van Velzen M, Dahan A. Nociception-guided versus Standard Care during Remifentanil-Propofol Anesthesia: A Randomized Controlled Trial. Anesthesiology. 2019 May;130(5):745-755. doi: 10.1097/ALN.0000000000002634.</citation>
    <PMID>30829658</PMID>
  </reference>
  <reference>
    <citation>Salmasi V, Maheshwari K, Yang D, Mascha EJ, Singh A, Sessler DI, Kurz A. Relationship between Intraoperative Hypotension, Defined by Either Reduction from Baseline or Absolute Thresholds, and Acute Kidney and Myocardial Injury after Noncardiac Surgery: A Retrospective Cohort Analysis. Anesthesiology. 2017 Jan;126(1):47-65.</citation>
    <PMID>27792044</PMID>
  </reference>
  <reference>
    <citation>Sessler DI, Bloomstone JA, Aronson S, Berry C, Gan TJ, Kellum JA, Plumb J, Mythen MG, Grocott MPW, Edwards MR, Miller TE; Perioperative Quality Initiative-3 workgroup; POQI chairs, Miller TE, Mythen MG, Grocott MP, Edwards MR; Physiology group; Preoperative blood pressure group; Intraoperative blood pressure group; Postoperative blood pressure group. Perioperative Quality Initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery. Br J Anaesth. 2019 May;122(5):563-574. doi: 10.1016/j.bja.2019.01.013. Epub 2019 Feb 27.</citation>
    <PMID>30916004</PMID>
  </reference>
  <reference>
    <citation>Danielson M, Wiklund A, Granath F, Blennow K, Mkrtchian S, Nellgård B, Oras J, Jonsson Fagerlund M, Granström A, Schening A, Rasmussen LS, Erlandsson Harris H, Zetterberg H, Ricksten SE, Eriksson LI. Neuroinflammatory markers associate with cognitive decline after major surgery: Findings of an explorative study. Ann Neurol. 2020 Mar;87(3):370-382. doi: 10.1002/ana.25678. Epub 2020 Jan 25.</citation>
    <PMID>31930549</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 14, 2021</study_first_submitted>
  <study_first_submitted_qc>July 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 15, 2021</study_first_posted>
  <last_update_submitted>July 5, 2021</last_update_submitted>
  <last_update_submitted_qc>July 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Nociception</keyword>
  <keyword>Entropy</keyword>
  <keyword>Analgesia</keyword>
  <keyword>Goal Directed Anesthesia Therapy (GDAT)</keyword>
  <keyword>Remifentanil</keyword>
  <keyword>Intraoperative Hypotension</keyword>
  <keyword>Myocardial Injury in Non-Cardiac Surgery (MINS)</keyword>
  <keyword>Postoperative Cognitive Dysfunction (POCD)</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

